Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Hydrocortisone-probutate | hsa00030 | Pentose phosphate pathway | 8.97E-03 | 1 | P11413 | G6PD | More | | Hydrocortisone-probutate | hsa00071 | Fatty acid degradation | 3.77E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | | Hydrocortisone-probutate | hsa00190 | Oxidative phosphorylation | 8.71E-03 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Hydrocortisone-probutate | hsa00220 | Arginine biosynthesis | 1.94E-03 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Hydrocortisone-probutate | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.32E-02 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Hydrocortisone-probutate | hsa00480 | Glutathione metabolism | 2.60E-05 | 5 | Q9UJ14, P11413, Q16772, P09211, P30041 | GGTL3, G6PD, GSTA3, GSTP1, PRDX6 | More | | Hydrocortisone-probutate | hsa00500 | Starch and sucrose metabolism | 5.41E-05 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Hydrocortisone-probutate | hsa00730 | Thiamine metabolism | 4.32E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Hydrocortisone-probutate | hsa00910 | Nitrogen metabolism | 4.32E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Hydrocortisone-probutate | hsa00970 | Aminoacyl-tRNA biosynthesis | 1.92E-04 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Hydrocortisone-probutate | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Hydrocortisone-probutate | hsa00982 | Drug metabolism - cytochrome P450 | 1.06E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Hydrocortisone-probutate | hsa00983 | Drug metabolism - other enzymes | 1.72E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Hydrocortisone-probutate | hsa01100 | Metabolic pathways | 8.43E-03 | 11 | P35790, Q16772, P09211, Q9UJ14, P30041, P40926, Q7KZN9, P15121, Q9UHK6, Q86VZ5, Q9BQB6 | CHKA, GSTA3, GSTP1, GGTL3, PRDX6, MDH2, COX15, AKR1B1, AMACR, SGMS1, VKORC1 | More | | Hydrocortisone-probutate | hsa01200 | Carbon metabolism | 2.91E-02 | 1 | P11413 | G6PD | More | | Hydrocortisone-probutate | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa01524 | Platinum drug resistance | 4.44E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Hydrocortisone-probutate | hsa03013 | RNA transport | 9.39E-05 | 9 | Q15287, Q9UBU9, P35658, P63279, P68104, P55884, O15371, P20042, Q14232 | RNPS1, NXF1, NUP214, UBE2I, EEF1A1, EIF3B, EIF3D, EIF2S2, EIF2B1 | More | | Hydrocortisone-probutate | hsa03040 | Spliceosome | 3.98E-02 | 4 | Q15427, P38159, P61978, P11142 | SF3B4, RBMX, HNRPK, HSPA8 | More | | Hydrocortisone-probutate | hsa03060 | Protein export | 9.07E-04 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Hydrocortisone-probutate | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04012 | ErbB signaling pathway | 8.14E-03 | 4 | P21860, Q13557, O14944, P04049 | ERBB3, CAMK2D, EREG, RAF1 | More | | Hydrocortisone-probutate | hsa04014 | Ras signaling pathway | 3.65E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04015 | Rap1 signaling pathway | 2.99E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04020 | Calcium signaling pathway | 2.19E-05 | 10 | Q96DU7, Q08828, P45880, Q13557, P21860, P61073, P0DP24, P05141, P51828, P23634 | ITPKC, ADCY1, VDAC2, CAMK2D, ERBB3, CXCR4, CALM2, SLC25A5, ADCY7, ATP2B4 | More | | Hydrocortisone-probutate | hsa04022 | cGMP-PKG signaling pathway | 9.49E-04 | 9 | P04049, Q99941, P18848, P23634, Q08828, P51828, P05141, P45880, P0DP24 | RAF1, CREBL1, ATF4, ATP2B4, ADCY1, ADCY7, SLC25A5, VDAC2, CALM2 | More | | Hydrocortisone-probutate | hsa04024 | cAMP signaling pathway | 2.49E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 9.15E-04 | 9 | Q8NHW4, P09341, P25024, P25025, P61073, P47992, Q9UBD3, Q13651, P01375 | CCL4L2, CXCL1, CXCR1, CXCR2, CXCR4, XCL1, XCL2, IL10RA, TNF | More | | Hydrocortisone-probutate | hsa04062 | Chemokine signaling pathway | 1.41E-02 | 9 | P25024, P25025, P07948, P42338, P63218, P50151, P49407, P04049, P49841 | CXCR1, CXCR2, LYN, PIK3CB, GNG5, GNG10, ARRB1, RAF1, GSK3B | More | | Hydrocortisone-probutate | hsa04064 | NF-kappa B signaling pathway | 1.25E-04 | 12 | P10415, Q13489, Q13546, P01584, P29965, Q9UDY8, Q8WV28, Q13315, P63279, Q8NHW4, Q9UNE0, Q9NQC7 | BCL2, BIRC3, RIPK1, IL1B, CD40LG, MALT1, BLNK, ATM, UBE2I, CCL4L2, EDAR, CYLD | More | | Hydrocortisone-probutate | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04070 | Phosphatidylinositol signaling system | 3.47E-02 | 4 | P0DP23, Q14643, P23743, P17252 | CALM1, ITPR1, DGKA, PRKCA | More | | Hydrocortisone-probutate | hsa04071 | Sphingolipid signaling pathway | 1.74E-02 | 5 | P04049, P17252, Q13362, Q9BX95, P10415 | RAF1, PRKCA, PPP2R5C, SGPP1, BCL2 | More | | Hydrocortisone-probutate | hsa04072 | Phospholipase D signaling pathway | 2.82E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04080 | Neuroactive ligand-receptor interaction | 3.70E-02 | 7 | P08311, P48058, Q15722, Q9H228, P43657, P21730, P35318 | CTSG, GRIA4, LTB4R, EDG8, P2RY5, C5AR1, ADM | More | | Hydrocortisone-probutate | hsa04114 | Oocyte meiosis | 4.36E-02 | 5 | Q13557, P0DP24, Q08828, P51828, P27348 | CAMK2D, CALM2, ADCY1, ADCY7, YWHAQ | More | | Hydrocortisone-probutate | hsa04140 | Autophagy - animal | 5.15E-02 | 6 | P04049, Q9NQL2, P22694, Q14643, Q9H1Y0, Q04759 | RAF1, RRAGD, PRKACB, ITPR1, ATG5, PRKCQ | More | | Hydrocortisone-probutate | hsa04141 | Protein processing in endoplasmic reticulum | 5.75E-03 | 7 | Q99941, O75460, P17861, P11142, Q9H3Z4, P07900, Q9NR31 | CREBL1, ERN1, XBP1, HSPA8, DNAJC5, HSP90AA1, SAR1A | More | | Hydrocortisone-probutate | hsa04145 | Phagosome | 1.59E-03 | 7 | Q15080, P14598, Q13509, P68371, Q13488, O60603, P13765 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, TLR2, HLA-DOB | More | | Hydrocortisone-probutate | hsa04150 | mTOR signaling pathway | 2.47E-02 | 5 | P42338, P04049, Q9NQL2, Q13322, P49841 | PIK3CB, RAF1, RRAGD, GRB10, GSK3B | More | | Hydrocortisone-probutate | hsa04151 | PI3K-Akt signaling pathway | 4.50E-02 | 9 | P25116, P49767, Q13362, P62873, P16144, O60603, P01568, P10415, P17252 | F2R, VEGFC, PPP2R5C, GNB1, ITGB4, TLR2, IFNA21, BCL2, PRKCA | More | | Hydrocortisone-probutate | hsa04210 | Apoptosis | 2.16E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04211 | Longevity regulating pathway | 3.41E-03 | 7 | Q12778, Q08828, P51828, Q99941, P18848, Q9UEF7, Q96KQ7 | FOXO1, ADCY1, ADCY7, CREBL1, ATF4, KL, EHMT2 | More | | Hydrocortisone-probutate | hsa04217 | Necroptosis | 2.08E-05 | 15 | P01568, P23458, Q13489, Q9NQC7, Q13546, P42224, P05141, P01584, P0C0S5, Q6FI13, P10415, Q13557, Q9H444, O43633, Q08752 | IFNA21, JAK1, BIRC3, CYLD, RIPK1, STAT1, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, BCL2, CAMK2D, CHMP4B, CHMP2A, PPID | More | | Hydrocortisone-probutate | hsa04218 | Cellular senescence | 2.49E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.49E-04 | 12 | P09493, Q08828, P51828, Q99941, P18848, Q13362, P0DP23, P0DP24, Q13557, P17252, P10415, P23634 | TPM1, ADCY1, ADCY7, CREBL1, ATF4, PPP2R5C, CALM1, CALM2, CAMK2D, PRKCA, BCL2, ATP2B4 | More | | Hydrocortisone-probutate | hsa04270 | Vascular smooth muscle contraction | 2.32E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Hydrocortisone-probutate | hsa04360 | Axon guidance | 2.49E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04370 | VEGF signaling pathway | 8.29E-03 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04371 | Apelin signaling pathway | 2.65E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04380 | Osteoclast differentiation | 6.08E-03 | 10 | Q9NQC7, Q9UQC2, Q16539, P23458, P06239, P42338, P01584, P14778, O75015, Q8N149 | CYLD, GAB2, MAPK14, JAK1, LCK, PIK3CB, IL1B, IL1R1, FCGR3B, LILRA2 | More | | Hydrocortisone-probutate | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04540 | Gap junction | 2.79E-03 | 5 | P17252, Q13509, P68371, P04049, Q14643 | PRKCA, TUBB3, TUBB2C, RAF1, ITPR1 | More | | Hydrocortisone-probutate | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04612 | Antigen processing and presentation | 3.60E-03 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Hydrocortisone-probutate | hsa04613 | Neutrophil extracellular trap formation | 1.74E-04 | 19 | P17252, P04049, O60603, P05164, P08246, Q9UM07, Q13547, Q6FI13, Q16778, P68431, P14598, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | PRKCA, RAF1, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC18; H2AC19, HIST2H2BE, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Hydrocortisone-probutate | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | | Hydrocortisone-probutate | hsa04621 | NOD-like receptor signaling pathway | 3.13E-04 | 17 | Q16539, Q14643, P01568, Q13489, P10599, Q9H1Y0, P43490, O00463, Q13546, P29728, Q05823, P01375, P09341, P49913, P59665, P59666, P12838 | MAPK14, ITPR1, IFNA21, BIRC3, TXN, ATG5, PBEF1, TRAF5, RIPK1, OAS2, RNASEL, TNF, CXCL1, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Hydrocortisone-probutate | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Hydrocortisone-probutate | hsa04623 | Cytosolic DNA-sensing pathway | 5.86E-05 | 4 | P01584, P01568, Q13546, Q8NHW4 | IL1B, IFNA21, RIPK1, CCL4L2 | More | | Hydrocortisone-probutate | hsa04625 | C-type lectin receptor signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04630 | JAK-STAT signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04640 | Hematopoietic cell lineage | 3.92E-04 | 11 | P13612, P14778, P27930, P15144, P25063, P07766, P09693, P01732, P01730, P13765, P01375 | ITGA4, IL1R1, IL1R2, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, HLA-DOB, TNF | More | | Hydrocortisone-probutate | hsa04650 | Natural killer cell mediated cytotoxicity | 2.28E-07 | 11 | P01375, P78314, P06239, O60880, P20963, P04049, Q13241, P26718, O75015, P26717, P26715 | TNF, SH3BP2, LCK, SH2D1A, CD247, RAF1, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Hydrocortisone-probutate | hsa04657 | IL-17 signaling pathway | 1.42E-02 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Hydrocortisone-probutate | hsa04658 | Th1 and Th2 cell differentiation | 2.79E-09 | 12 | Q04759, P07766, P20963, P09693, Q16539, P01730, P06239, Q14765, P23771, Q9UL17, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, CD4, LCK, STAT4, GATA3, TBX21, HLA-DOB, RUNX3 | More | | Hydrocortisone-probutate | hsa04659 | Th17 cell differentiation | 1.17E-07 | 11 | Q04759, Q16539, P01730, P06239, P13765, P14778, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, MAPK14, CD4, LCK, HLA-DOB, IL1R1, TBX21, GATA3, CD3E, CD3G, CD247 | More | | Hydrocortisone-probutate | hsa04660 | T cell receptor signaling pathway | 7.66E-09 | 15 | P01375, Q04759, P42338, O95267, Q08881, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, P04049, Q16539, P49841 | TNF, PRKCQ, PIK3CB, RASGRP1, ITK, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, RAF1, MAPK14, GSK3B | More | | Hydrocortisone-probutate | hsa04662 | B cell receptor signaling pathway | 1.99E-04 | 7 | P49841, P42338, P60033, P07948, P21854, Q8N149, P04049 | GSK3B, PIK3CB, CD81, LYN, CD72, LILRA2, RAF1 | More | | Hydrocortisone-probutate | hsa04664 | Fc epsilon RI signaling pathway | 4.03E-03 | 5 | Q16539, P42338, P07948, P04049, P09917 | MAPK14, PIK3CB, LYN, RAF1, ALOX5 | More | | Hydrocortisone-probutate | hsa04666 | Fc gamma R-mediated phagocytosis | 2.32E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04668 | TNF signaling pathway | 4.74E-02 | 3 | Q99941, P01584, O95429 | CREBL1, IL1B, BAG4 | More | | Hydrocortisone-probutate | hsa04672 | Intestinal immune network for IgA production | 3.76E-03 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Hydrocortisone-probutate | hsa04713 | Circadian entrainment | 1.25E-03 | 8 | P0DP23, P0DP24, Q13557, P17252, P62873, Q14643, Q08828, P51828 | CALM1, CALM2, CAMK2D, PRKCA, GNB1, ITPR1, ADCY1, ADCY7 | More | | Hydrocortisone-probutate | hsa04720 | Long-term potentiation | 7.87E-04 | 8 | P17252, Q13557, P0DP23, P0DP24, P18848, Q08828, P04049, Q14643 | PRKCA, CAMK2D, CALM1, CALM2, ATF4, ADCY1, RAF1, ITPR1 | More | | Hydrocortisone-probutate | hsa04722 | Neurotrophin signaling pathway | 4.44E-04 | 3 | Q05655, P04049, P52566 | PRKCD, RAF1, ARHGDIB | More | | Hydrocortisone-probutate | hsa04723 | Retrograde endocannabinoid signaling | 1.88E-03 | 8 | Q14643, P17252, P62873, P63218, P50151, P48058, Q16539, Q16718 | ITPR1, PRKCA, GNB1, GNG5, GNG10, GRIA4, MAPK14, NDUFA5 | More | | Hydrocortisone-probutate | hsa04724 | Glutamatergic synapse | 7.09E-03 | 5 | P48058, P43003, P63218, P50151, P15104 | GRIA4, SLC1A3, GNG5, GNG10, GLUL | More | | Hydrocortisone-probutate | hsa04725 | Cholinergic synapse | 1.75E-03 | 8 | Q08828, P51828, Q14643, P17252, P62873, P18848, Q13557, P10415 | ADCY1, ADCY7, ITPR1, PRKCA, GNB1, ATF4, CAMK2D, BCL2 | More | | Hydrocortisone-probutate | hsa04726 | Serotonergic synapse | 1.33E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04728 | Dopaminergic synapse | 1.89E-04 | 16 | Q14643, P17252, P62873, P63218, P50151, P49841, Q99941, P18848, Q16539, Q13557, P49407, Q13362, P0DP23, P0DP24, O15516, P48058 | ITPR1, PRKCA, GNB1, GNG5, GNG10, GSK3B, CREBL1, ATF4, MAPK14, CAMK2D, ARRB1, PPP2R5C, CALM1, CALM2, CLOCK, GRIA4 | More | | Hydrocortisone-probutate | hsa04730 | Long-term depression | 1.16E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04744 | Phototransduction | 1.02E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Hydrocortisone-probutate | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.58E-05 | 10 | P14778, P01584, Q08828, P51828, P22694, Q13557, Q16539, Q14643, Q04759, P0DP24 | IL1R1, IL1B, ADCY1, ADCY7, PRKACB, CAMK2D, MAPK14, ITPR1, PRKCQ, CALM2 | More | | Hydrocortisone-probutate | hsa04810 | Regulation of actin cytoskeleton | 3.81E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04910 | Insulin signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04911 | Insulin secretion | 2.95E-05 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | | Hydrocortisone-probutate | hsa04912 | GnRH signaling pathway | 3.21E-04 | 9 | P17252, Q08828, P51828, P18848, Q13557, Q14643, P0DP23, P0DP24, P04049 | PRKCA, ADCY1, ADCY7, ATF4, CAMK2D, ITPR1, CALM1, CALM2, RAF1 | More | | Hydrocortisone-probutate | hsa04914 | Progesterone-mediated oocyte maturation | 2.16E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04915 | Estrogen signaling pathway | 1.26E-02 | 5 | P04049, Q99941, P51828, P07900, P11142 | RAF1, CREBL1, ADCY7, HSP90AA1, HSPA8 | More | | Hydrocortisone-probutate | hsa04916 | Melanogenesis | 1.80E-03 | 5 | Q13557, P0DP24, Q08828, P51828, P04049 | CAMK2D, CALM2, ADCY1, ADCY7, RAF1 | More | | Hydrocortisone-probutate | hsa04917 | Prolactin signaling pathway | 6.63E-03 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04918 | Thyroid hormone synthesis | 4.47E-03 | 5 | Q08828, P51828, Q99941, P18848, P02768 | ADCY1, ADCY7, CREBL1, ATF4, ALB | More | | Hydrocortisone-probutate | hsa04919 | Thyroid hormone signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04921 | Oxytocin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04922 | Glucagon signaling pathway | 3.47E-02 | 4 | Q12778, Q13370, P0DP23, Q14643 | FOXO1, PDE3B, CALM1, ITPR1 | More | | Hydrocortisone-probutate | hsa04924 | Renin secretion | 8.71E-03 | 3 | Q14643, Q13370, P0DP23 | ITPR1, PDE3B, CALM1 | More | | Hydrocortisone-probutate | hsa04925 | Aldosterone synthesis and secretion | 8.00E-06 | 7 | Q99941, P18848, Q08828, P51828, P0DP24, Q13557, P23634 | CREBL1, ATF4, ADCY1, ADCY7, CALM2, CAMK2D, ATP2B4 | More | | Hydrocortisone-probutate | hsa04926 | Relaxin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04927 | Cortisol synthesis and secretion | 4.16E-03 | 4 | Q99941, P18848, Q08828, P51828 | CREBL1, ATF4, ADCY1, ADCY7 | More | | Hydrocortisone-probutate | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.20E-02 | 5 | Q08828, P51828, P04049, Q99941, P18848 | ADCY1, ADCY7, RAF1, CREBL1, ATF4 | More | | Hydrocortisone-probutate | hsa04929 | GnRH secretion | 4.98E-03 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa04930 | Type II diabetes mellitus | 2.68E-02 | 1 | Q05655 | PRKCD | More | | Hydrocortisone-probutate | hsa04932 | Non-alcoholic fatty liver disease | 3.45E-02 | 5 | P18848, O75460, P01584, P12074, O15239 | ATF4, ERN1, IL1B, COX6A1, NDUFA1 | More | | Hydrocortisone-probutate | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.27E-02 | 5 | P42224, P10415, Q12778, P49767, P17252 | STAT1, BCL2, FOXO1, VEGFC, PRKCA | More | | Hydrocortisone-probutate | hsa04934 | Cushing syndrome | 2.69E-06 | 6 | Q99941, P18848, Q08828, P51828, O15169, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, AXIN1, CAMK2D | More | | Hydrocortisone-probutate | hsa04935 | Growth hormone synthesis, secretion and action | 1.68E-02 | 5 | Q08828, P51828, P04049, Q99941, P18848 | ADCY1, ADCY7, RAF1, CREBL1, ATF4 | More | | Hydrocortisone-probutate | hsa04966 | Collecting duct acid secretion | 2.86E-02 | 2 | Q13488, Q9Y666 | TCIRG1, SLC12A7 | More | | Hydrocortisone-probutate | hsa04970 | Salivary secretion | 3.54E-02 | 3 | Q08828, P51828, P0DP24 | ADCY1, ADCY7, CALM2 | More | | Hydrocortisone-probutate | hsa04971 | Gastric acid secretion | 2.95E-05 | 5 | Q08828, P51828, P15311, P0DP24, Q13557 | ADCY1, ADCY7, VIL2, CALM2, CAMK2D | More | | Hydrocortisone-probutate | hsa04973 | Carbohydrate digestion and absorption | 1.57E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Hydrocortisone-probutate | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | | Hydrocortisone-probutate | hsa05010 | Alzheimer disease | 7.87E-06 | 24 | Q92542, O15239, Q16718, O14521, P05496, Q06055, P12074, Q14643, Q00535, O75460, P0DP23, P0DP24, P01584, P18848, Q13509, P68371, O15169, P05141, P45880, Q08752, P17861, P28070, P43686, P62195 | NCSTN, NDUFA1, NDUFA5, SDHD, ATP5G1, ATP5G2, COX6A1, ITPR1, CDK5, ERN1, CALM1, CALM2, IL1B, ATF4, TUBB3, TUBB2C, AXIN1, SLC25A5, VDAC2, PPID, XBP1, PSMB4, PSMC4, PSMC5 | More | | Hydrocortisone-probutate | hsa05012 | Parkinson disease | 9.44E-05 | 18 | O15239, Q16718, O14521, P12074, Q06055, P05141, O75460, P18848, P17861, P28070, P43686, P62195, Q14643, P0DP23, P0DP24, Q13557, Q13509, P68371 | NDUFA1, NDUFA5, SDHD, COX6A1, ATP5G2, SLC25A5, ERN1, ATF4, XBP1, PSMB4, PSMC4, PSMC5, ITPR1, CALM1, CALM2, CAMK2D, TUBB3, TUBB2C | More | | Hydrocortisone-probutate | hsa05014 | Amyotrophic lateral sclerosis | 1.01E-02 | 3 | Q06055, P17861, P62195 | ATP5G2, XBP1, PSMC5 | More | | Hydrocortisone-probutate | hsa05016 | Huntington disease | 3.54E-02 | 8 | O15239, P12074, P24928, P62487, P05141, O75460, P28070, P43686 | NDUFA1, COX6A1, POLR2A, POLR2G, SLC25A5, ERN1, PSMB4, PSMC4 | More | | Hydrocortisone-probutate | hsa05017 | Spinocerebellar ataxia | 1.42E-02 | 2 | P17861, P62195 | XBP1, PSMC5 | More | | Hydrocortisone-probutate | hsa05020 | Prion disease | 9.80E-05 | 19 | P01584, P46531, P11142, O15239, Q16718, O14521, P05496, P12074, Q14643, P18848, P05141, P45880, P28070, P43686, Q13509, P68371, Q99941, P14598, Q15080 | IL1B, NOTCH1, HSPA8, NDUFA1, NDUFA5, SDHD, ATP5G1, COX6A1, ITPR1, ATF4, SLC25A5, VDAC2, PSMB4, PSMC4, TUBB3, TUBB2C, CREBL1, NCF1, NCF4 | More | | Hydrocortisone-probutate | hsa05022 | Pathways of neurodegeneration - multiple diseases | 8.91E-06 | 26 | Q14643, Q13509, P68371, P10415, O15239, Q16718, O14521, P12074, Q06055, Q8TEV9, O75460, P18848, P17861, Q13561, P05141, P17252, Q00535, O15169, P01584, Q08752, P0DP23, P0DP24, Q13557, P28070, P43686, P62195 | ITPR1, TUBB3, TUBB2C, BCL2, NDUFA1, NDUFA5, SDHD, COX6A1, ATP5G2, SMCR8, ERN1, ATF4, XBP1, DCTN2, SLC25A5, PRKCA, CDK5, AXIN1, IL1B, PPID, CALM1, CALM2, CAMK2D, PSMB4, PSMC4, PSMC5 | More | | Hydrocortisone-probutate | hsa05030 | Cocaine addiction | 3.54E-02 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | | Hydrocortisone-probutate | hsa05031 | Amphetamine addiction | 7.61E-03 | 4 | P0DP24, Q13557, Q99941, P18848 | CALM2, CAMK2D, CREBL1, ATF4 | More | | Hydrocortisone-probutate | hsa05034 | Alcoholism | 2.49E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.47E-03 | 5 | Q16539, P09341, P25024, P25025, P07948 | MAPK14, CXCL1, CXCR1, CXCR2, LYN | More | | Hydrocortisone-probutate | hsa05131 | Shigellosis | 3.99E-03 | 10 | P68431, Q05655, Q9UDY8, Q14247, Q14643, Q12778, Q13315, P10415, Q08752, P07737 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, PRKCD, MALT1, CTTN, ITPR1, FOXO1, ATM, BCL2, PPID, PFN1 | More | | Hydrocortisone-probutate | hsa05132 | Salmonella infection | 1.08E-04 | 13 | P04049, Q9UJU2, P84095, Q13546, Q13489, P10415, P07737, O60603, Q9BQS8, Q13561, O60282, Q13509, P68371 | RAF1, LEF1, RHOG, RIPK1, BIRC3, BCL2, PFN1, TLR2, FYCO1, DCTN2, KIF5C, TUBB3, TUBB2C | More | | Hydrocortisone-probutate | hsa05134 | Legionellosis | 5.53E-03 | 2 | Q9NR31, P68104 | SAR1A, EEF1A1 | More | | Hydrocortisone-probutate | hsa05135 | Yersinia infection | 5.36E-05 | 8 | P13612, P06239, Q16539, P01375, P42338, P49841, P01730, P01732 | ITGA4, LCK, MAPK14, TNF, PIK3CB, GSK3B, CD4, CD8A | More | | Hydrocortisone-probutate | hsa05140 | Leishmaniasis | 2.45E-04 | 10 | P13612, O75015, P14598, P42224, P13765, O60603, P01375, P29350, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, STAT1, HLA-DOB, TLR2, TNF, PTPN6, MAPK14, NCF4 | More | | Hydrocortisone-probutate | hsa05144 | Malaria | 6.84E-04 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Hydrocortisone-probutate | hsa05145 | Toxoplasmosis | 1.11E-02 | 6 | P10415, Q13489, P42224, P13765, O60603, P29965 | BCL2, BIRC3, STAT1, HLA-DOB, TLR2, CD40LG | More | | Hydrocortisone-probutate | hsa05146 | Amoebiasis | 4.74E-05 | 9 | P09341, P14778, P27930, P01375, O60603, P05089, P22694, P12814, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, ACTN1, CTSG | More | | Hydrocortisone-probutate | hsa05150 | Staphylococcus aureus infection | 1.02E-03 | 7 | P21730, P21462, O75015, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Hydrocortisone-probutate | hsa05152 | Tuberculosis | 9.31E-04 | 9 | P04049, Q13488, P0DP23, P42224, O60603, P10415, P13765, P01568, Q9UDY8 | RAF1, TCIRG1, CALM1, STAT1, TLR2, BCL2, HLA-DOB, IFNA21, MALT1 | More | | Hydrocortisone-probutate | hsa05160 | Hepatitis C | 1.99E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05161 | Hepatitis B | 1.99E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05163 | Human cytomegalovirus infection | 2.07E-06 | 22 | P42338, P04049, P01375, P63218, P50151, Q14643, P0DP24, Q8NHW4, Q08828, P51828, P22694, P23458, P49841, P14778, P01584, P61073, Q13651, P25025, Q16539, Q99941, P18848, O00463 | PIK3CB, RAF1, TNF, GNG5, GNG10, ITPR1, CALM2, CCL4L2, ADCY1, ADCY7, PRKACB, JAK1, GSK3B, IL1R1, IL1B, CXCR4, IL10RA, CXCR2, MAPK14, CREBL1, ATF4, TRAF5 | More | | Hydrocortisone-probutate | hsa05164 | Influenza A | 3.65E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05165 | Human papillomavirus infection | 3.10E-02 | 8 | P16144, Q05086, P01568, P42224, Q13488, Q13362, Q12778, Q13315 | ITGB4, UBE3A, IFNA21, STAT1, TCIRG1, PPP2R5C, FOXO1, ATM | More | | Hydrocortisone-probutate | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.48E-02 | 7 | P01568, P42224, P62873, Q14643, P04049, P0DP23, Q9UJU2 | IFNA21, STAT1, GNB1, ITPR1, RAF1, CALM1, LEF1 | More | | Hydrocortisone-probutate | hsa05169 | Epstein-Barr virus infection | 2.32E-02 | 9 | Q13547, O00463, Q16539, P42338, P07948, Q13761, P24522, P07766, P20963 | HDAC1, TRAF5, MAPK14, PIK3CB, LYN, RUNX3, GADD45A, CD3E, CD247 | More | | Hydrocortisone-probutate | hsa05170 | Human immunodeficiency virus 1 infection | 8.78E-04 | 10 | P04049, P62873, P0DP23, P17252, Q14643, P01568, O60603, Q13315, P10415, Q9Y6Q5 | RAF1, GNB1, CALM1, PRKCA, ITPR1, IFNA21, TLR2, ATM, BCL2, AP1M2 | More | | Hydrocortisone-probutate | hsa05200 | Pathways in cancer | 4.99E-02 | 12 | P42224, Q9UJU2, P17252, P14923, P10415, Q13489, P49767, Q12778, P25116, P62873, P0DP23, P01568 | STAT1, LEF1, PRKCA, JUP, BCL2, BIRC3, VEGFC, FOXO1, F2R, GNB1, CALM1, IFNA21 | More | | Hydrocortisone-probutate | hsa05202 | Transcriptional misregulation in cancer | 3.51E-02 | 12 | P14780, P27930, Q15744, Q16548, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, P12980, P24522 | MMP9, IL1R2, CEBPE, BCL2A1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, LYL1, GADD45A | More | | Hydrocortisone-probutate | hsa05203 | Viral carcinogenesis | 4.62E-02 | 3 | Q12933, P42229, Q15283 | TRAF2, STAT5A, RASA2 | More | | Hydrocortisone-probutate | hsa05204 | Chemical carcinogenesis | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Hydrocortisone-probutate | hsa05205 | Proteoglycans in cancer | 3.48E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05206 | MicroRNAs in cancer | 6.19E-04 | 7 | P15311, P21860, P61978, P46531, P63279, P22105, P04049 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB, RAF1 | More | | Hydrocortisone-probutate | hsa05210 | Colorectal cancer | 1.66E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05211 | Renal cell carcinoma | 1.16E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05212 | Pancreatic cancer | 1.16E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05213 | Endometrial cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05214 | Glioma | 9.95E-03 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05218 | Melanoma | 6.63E-03 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05219 | Bladder cancer | 4.98E-03 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05220 | Chronic myeloid leukemia | 9.95E-03 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05221 | Acute myeloid leukemia | 8.29E-03 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05223 | Non-small cell lung cancer | 6.63E-03 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05224 | Breast cancer | 1.49E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05226 | Gastric cancer | 8.29E-03 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05230 | Central carbon metabolism in cancer | 1.00E-04 | 2 | P04049, P11413 | RAF1, G6PD | More | | Hydrocortisone-probutate | hsa05231 | Choline metabolism in cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | | Hydrocortisone-probutate | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.65E-06 | 11 | P42338, O95267, P07766, P20963, P09693, P06239, P04049, O60603, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, CD3E, CD247, CD3G, LCK, RAF1, TLR2, PRKCQ, MAPK14, CD4 | More | | Hydrocortisone-probutate | hsa05310 | Asthma | 1.62E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Hydrocortisone-probutate | hsa05320 | Autoimmune thyroid disease | 1.27E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Hydrocortisone-probutate | hsa05321 | Inflammatory bowel disease | 1.09E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Hydrocortisone-probutate | hsa05322 | Systemic lupus erythematosus | 4.18E-03 | 7 | P08246, P09871, P10747, P13765, P29965, Q6FI13, P68431 | ELA2, C1S, CD28, HLA-DOB, CD40LG, H2AC18; H2AC19, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Hydrocortisone-probutate | hsa05323 | Rheumatoid arthritis | 1.29E-02 | 4 | P13765, Q13488, P10747, O60603 | HLA-DOB, TCIRG1, CD28, TLR2 | More | | Hydrocortisone-probutate | hsa05330 | Allograft rejection | 1.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Hydrocortisone-probutate | hsa05332 | Graft-versus-host disease | 1.76E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | Hydrocortisone-probutate | hsa05340 | Primary immunodeficiency | 3.76E-02 | 4 | P01730, P01732, P07766, P06239 | CD4, CD8A, CD3E, LCK | More | | Hydrocortisone-probutate | hsa05415 | Diabetic cardiomyopathy | 2.33E-02 | 6 | P17252, P14598, Q15080, Q16718, O14521, P11413 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, G6PD | More | | Hydrocortisone-probutate | hsa05416 | Viral myocarditis | 2.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | |